May 29, 2024 · Form 4 insider transaction
Mirviss Jeffrey B. bought 33,726 shares of Boston Scientific Corporation at $17.26 per share, a transaction worth $582.1K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
The transaction reported in this Form 4 was effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on February 28, 2024.